报价延迟最少15分钟:2025/08/11 00:37 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
29.21 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-13.22/--
|
|
企业价值
89.04M
|
| 资产负债 |
|
每股账面净值
1.67
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/08/11 00:37 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property. |
